Everest Medicines Limited (HKG:1952)

Everest Medicines Statistics

Total Valuation

HKG:1952 has a market cap or net worth of HKD 19.41 billion. The enterprise value is 18.48 billion.

Market Cap	19.41B
Enterprise Value	18.48B

Important Dates

The next estimated earnings date is Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:1952 has 353.25 million shares outstanding. The number of shares has increased by 0.25% in one year.

Current Share Class	353.25M
Shares Outstanding	353.25M
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.07%
Owned by Institutions (%)	12.11%
Float	264.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.81
PB Ratio	4.51
P/TBV Ratio	10.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-25.60
EV / Sales	19.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-34.58

Financial Position

The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.19.

Current Ratio	5.46
Quick Ratio	5.36
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	-1.51
Interest Coverage	-31.72

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-15.87%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	665
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +116.51% in the last 52 weeks. The beta is 1.61, so HKG:1952's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	+116.51%
50-Day Moving Average	65.35
200-Day Moving Average	53.77
Relative Strength Index (RSI)	37.76
Average Volume (20 Days)	4,936,860

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1952 had revenue of HKD 932.82 million and -721.85 million in losses. Loss per share was -2.23.

Revenue	932.82M
Gross Profit	654.41M
Operating Income	-795.72M
Pretax Income	-721.85M
Net Income	-721.85M
EBITDA	-651.63M
EBIT	-795.72M
Loss Per Share	-2.23

Balance Sheet

The company has 1.74 billion in cash and 805.37 million in debt, giving a net cash position of 932.44 million or 2.64 per share.

Cash & Cash Equivalents	1.74B
Total Debt	805.37M
Net Cash	932.44M
Net Cash Per Share	2.64
Equity (Book Value)	4.30B
Book Value Per Share	13.14
Working Capital	1.75B

Cash Flow

In the last 12 months, operating cash flow was -488.76 million and capital expenditures -45.63 million, giving a free cash flow of -534.39 million.

Operating Cash Flow	-488.76M
Capital Expenditures	-45.63M
Free Cash Flow	-534.39M
FCF Per Share	-1.51

Margins

Gross margin is 70.15%, with operating and profit margins of -85.30% and -77.38%.

Gross Margin	70.15%
Operating Margin	-85.30%
Pretax Margin	-77.38%
Profit Margin	-77.38%
EBITDA Margin	-69.86%
EBIT Margin	-85.30%
FCF Margin	n/a

Dividends & Yields

HKG:1952 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.25%
Shareholder Yield	n/a
Earnings Yield	-3.72%
FCF Yield	-2.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1952 has an Altman Z-Score of 3.97 and a Piotroski F-Score of 1.

Altman Z-Score	3.97
Piotroski F-Score	1